KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Liabilities and Shareholders Equity (2016 - 2026)

Eli Lilly filings provide 18 years of Liabilities and Shareholders Equity readings, the most recent being $116.6 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 30.41% to $116.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $444.9 billion, a 40.98% increase, with the full-year FY2025 number at $112.5 billion, up 42.89% from a year prior.
  • Liabilities and Shareholders Equity hit $116.6 billion in Q1 2026 for Eli Lilly, up from $112.5 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $116.6 billion in Q1 2026 to a low of $46.9 billion in Q1 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $64.0 billion (2023), compared with a mean of $73.3 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: dropped 1.56% in 2022 and later soared 52.02% in 2025.
  • Eli Lilly's Liabilities and Shareholders Equity stood at $49.5 billion in 2022, then rose by 29.33% to $64.0 billion in 2023, then rose by 22.98% to $78.7 billion in 2024, then soared by 42.89% to $112.5 billion in 2025, then increased by 3.65% to $116.6 billion in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $116.6 billion (Q1 2026), $112.5 billion (Q4 2025), and $114.9 billion (Q3 2025) per Business Quant data.